These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 25109569)

  • 1. Translational potential of naloxone and naltrexone as TLR4 antagonists.
    Skolnick P; Davis H; Arnelle D; Deaver D
    Trends Pharmacol Sci; 2014 Sep; 35(9):431-2. PubMed ID: 25109569
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo veritas: (+)-Naltrexone's actions define translational importance: A letter in response to Skolnick et al. 'Translational potential of naloxone and naltrexone as TLR4 antagonists'.
    Watkins LR; Wang X; Mustafa S; Hutchinson MR
    Trends Pharmacol Sci; 2014 Sep; 35(9):432-3. PubMed ID: 25109571
    [No Abstract]   [Full Text] [Related]  

  • 3. Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages.
    Franchi S; Moretti S; Castelli M; Lattuada D; Scavullo C; Panerai AE; Sacerdote P
    Brain Behav Immun; 2012 Mar; 26(3):480-8. PubMed ID: 22240038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia.
    Watkins LR; Hutchinson MR; Rice KC; Maier SF
    Trends Pharmacol Sci; 2009 Nov; 30(11):581-91. PubMed ID: 19762094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-Activity Relationships of (+)-Naltrexone-Inspired Toll-like Receptor 4 (TLR4) Antagonists.
    Selfridge BR; Wang X; Zhang Y; Yin H; Grace PM; Watkins LR; Jacobson AE; Rice KC
    J Med Chem; 2015 Jun; 58(12):5038-52. PubMed ID: 26010811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonists of toll like receptor 4 maybe a new strategy to counteract opioid-induced hyperalgesia and opioid tolerance.
    Li Q
    Med Hypotheses; 2012 Dec; 79(6):754-6. PubMed ID: 23062774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A structural insight into the negative effects of opioids in analgesia by modulating the TLR4 signaling: An in silico approach.
    Shah M; Anwar MA; Yesudhas D; Krishnan J; Choi S
    Sci Rep; 2016 Dec; 6():39271. PubMed ID: 27982096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effects of the Toll-Like Receptor 4 Antagonist, Ibudilast, on Sevoflurane's Minimum Alveolar Concentration and the Delayed Remifentanil-Induced Increase in the Minimum Alveolar Concentration in Rats.
    Ruiz-Pérez D; Benito J; Polo G; Largo C; Aguado D; Sanz L; Gómez de Segura IA
    Anesth Analg; 2016 May; 122(5):1370-6. PubMed ID: 26859874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between narcotic agonists, partial agonists and antagonists evaluated by schedule-controlled behavior.
    Harris RA
    J Pharmacol Exp Ther; 1980 Jun; 213(3):497-503. PubMed ID: 6110766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects of narcotic analgesics administered alone or in combination with narcotic antagonists.
    Hartmann RJ; Geller I
    Proc West Pharmacol Soc; 1976; 19():243-7. PubMed ID: 11501
    [No Abstract]   [Full Text] [Related]  

  • 11. Nalmefene Prevents Alcohol-Induced Neuroinflammation and Alcohol Drinking Preference in Adolescent Female Mice: Role of TLR4.
    Montesinos J; Gil A; Guerri C
    Alcohol Clin Exp Res; 2017 Jul; 41(7):1257-1270. PubMed ID: 28493563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal in humans.
    Eissenberg T; Greenwald MK; Johnson RE; Liebson IA; Bigelow GE; Stitzer ML
    J Pharmacol Exp Ther; 1996 Feb; 276(2):449-59. PubMed ID: 8632309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opiate receptor pharmacology: mixed agonist/antagonist narcotics.
    Hameroff SR
    Contemp Anesth Pract; 1983; 7():27-43. PubMed ID: 6136392
    [No Abstract]   [Full Text] [Related]  

  • 14. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS).
    Kalra A; Urban MO; Sluka KA
    J Pharmacol Exp Ther; 2001 Jul; 298(1):257-63. PubMed ID: 11408550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine attenuates the expression of sensitization to ethanol, but opioid antagonists do not.
    Abrahao KP; Quadros IM; Souza-Formigoni ML
    Neuroscience; 2008 Oct; 156(4):857-64. PubMed ID: 18804151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone acts as a potent analgesic in transgenic mouse models of sickle cell anemia.
    Lunzer MM; Yekkirala A; Hebbel RP; Portoghese PS
    Proc Natl Acad Sci U S A; 2007 Apr; 104(14):6061-5. PubMed ID: 17389363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [N-allyl-Dmt1]-endomorphins are micro-opioid receptor antagonists lacking inverse agonist properties.
    Marczak ED; Jinsmaa Y; Li T; Bryant SD; Tsuda Y; Okada Y; Lazarus LH
    J Pharmacol Exp Ther; 2007 Oct; 323(1):374-80. PubMed ID: 17626793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid adjuvant strategy: improving opioid effectiveness.
    Bihel F
    Future Med Chem; 2016; 8(3):339-54. PubMed ID: 26898358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the morphine-induced inhibition of small and large intestinal transit: Involvement of central and peripheral μ-opioid receptors in mice.
    Matsumoto K; Umemoto H; Mori T; Akatsu R; Saito S; Tashima K; Shibasaki M; Kato S; Suzuki T; Horie S
    Eur J Pharmacol; 2016 Jan; 771():220-8. PubMed ID: 26712376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.